SECsense Logo

Pulse Biosciences, Inc. 8-K Report: Key Developments for Investors

$PLSE
Form 8-K
Filed on: 2025-01-14
Source
Pulse Biosciences, Inc. 8-K Report: Key Developments for Investors

Here are the key pieces of information extracted from the provided financial report section:

  1. Entity Information:
  • Company Name: Pulse Biosciences, Inc.
  • CIK (Central Index Key): 0001625101
  • SEC File Number: 001-37744
  • EIN (Employer Identification Number): 46-5696597
  • Address: 601 Brickell Key Drive, Suite 1080, Miami, FL 33131
  • Phone Number: 510-906-4600
  1. Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: January 14, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.001 per share
  • Ticker Symbol: PLSE
  • Exchange: NASDAQ
  1. Period of Report:
  • Start Date: January 14, 2025
  • End Date: January 14, 2025
  1. Schema Reference:
  • Schema Reference File: plse-20250114.xsd

Insights:

  • The report is an 8-K filing, which typically includes significant events or corporate changes that may be of interest to investors.
  • The company is listed on NASDAQ, which indicates a level of regulatory compliance and public market participation.
  • The specific dates indicate that this report covers a very singular event or announcement that occurred on the same day it was filed, suggesting urgency or importance in the disclosure.
  • The low par value of the stock may imply that the company is in a growth phase, as many startups and biotech firms often have low par values to maximize capital flexibility.

This information is crucial for investors and analysts who may be evaluating the company’s recent developments and overall market position.